Angel Lee, reconocida por impulsar desarrollo del primer medicamento recetado para fatiga por cáncer

RegulatoryapprovedPG2Positive

AI Analysis

Summary

PhytoHealth's PG2 has been recognized as the first botanical drug approved for cancer-related fatigue, with CEO Angel Lee recognized for leading its development.

Outcome Details

First botanical drug approved for cancer-related fatigue

Importance:7/10

Sentiment:

0.70

FDA ApprovalFirst-in-ClassBotanical DrugCancer IndicationLeadership Recognition

Read the original article

Published by PR Newswire Biotech on October 2, 2026 11:18 AM

Read Original